Abstract:IMPORTANCE: Pericarditis is the most common cardiac manifestation of Systemic Lupus Erythematosus (SLE) and known to recur among patients. Yet, the prevalence and risk factors of recurrent pericarditis in SLE patients are unknown. OBJECTIVE: Determine the frequency and risk factors for the recurrence of pericarditis in patients with SLE. DESIGN: Retrospective analysis of a well–characterized, prospective cohort of SLE patients enrolled between 1988 and 2023. SETTING: A single–center cohort study of a diverse group of SLE patients treated at a tertiary medical center. PARTICIPANTS: Patients diagnosed with pericarditis (n=590) among those enrolled in the Hopkins Lupus Cohort (n=2931). MAIN OUTCOME: Re–occurrence of pericarditis. The SELENA revision of the SLE Disease Activity Index (SLEDAI) was used to define pericarditis. Clinical information was examined for all follow–up encounters after the first episode of pericarditis. Pericarditis that occurred at least six weeks after the first recorded episode was defined as Recurrent. RESULTS. Of 2931 patients within the cohort, 590 had a history of pericarditis. In 3.4% of patients, the diagnosis of pericarditis was confirmed via electrocardiogram (EKG) or dedicated imaging, with 100% concordance between clinical and data–based diagnoses. During a median follow–up of 7 years (IQR: 3 – 14), 20% (n=120) of patients experienced recurrent pericarditis (recurrence rate ≈ 0.05 per person–year of follow–up). Most patients (51%) experienced only one recurrence, whereas 49% had ≥2 recurrences. In multivariate analysis, predictors of recurrence included younger age (≥60 years vs. <40, RR 0.11 (0.04, 0.32), P <.001), treatment with prednisone (≥20 vs. 0 mg, RR 1.99 (1.17, 3.40), P = 0.012), active SLE disease (SLEDAI ≥3 vs. 0, RR 1.55 (1.21, 2.00), P <.001), and time since initial episode (3–10 years vs. <1, RR 0.32 (0.20, 0.52), P <.001). CONCLUSION AND RELEVANCE. Recurrence is more likely to occur within one year of the onset of pericarditis, and younger patients and those with uncontrolled disease are at greater risk of recurrence. As in the general population, oral prednisone therapy is associated with a higher chance of recurrence in SLE patients, with a dose–dependent effect. These findings set the basis for future studies to define optimal treatment for recurrent pericarditis in SLE patients and suggest that oral corticosteroids should be avoided when treating pericarditis.

Genetic variants in patients with recurrent pericarditis

Whole exome sequencing in patients with recurrent pericarditis

Long-Term Data from a Longitudinal Retrospective Single-Centre Cohort

Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis

Aetiological diagnosis in acute and recurrent pericarditis: when and how

Role of genetics in inflammatory cardiomyopathy

Integrating in Padua Cohort Literature-Derived Data

D-Dimer and procalcitonin in patients with recurrent pericarditis: a prospective study

Pericarditis recurrence is associated with milder electrocardiographic, echocardiographic, and laboratory findings

Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study

The Genetic Landscape of Systemic Rheumatic Diseases: A Comprehensive Multigene-Panel Study Identifying Key Gene Polymorphisms

Incidence and Predictors of Recurrent Pericarditis in Systemic Lupus Erythematosus

Polygenic Prediction of Recurrent Events After Early-Onset Myocardial Infarction

The Role of the R202Q Variant of the MEFV Gene

Identification by Exome Sequencing of Predisposing Variants in Familial Cases of Autoinflammatory Recurrent Fevers

Redefining genotype-phenotype correlation among patients with arrhythmogenic cardiomyopathy: a CMR cohort study

Recurrent pericarditis in older adults: Clinical and laboratory features and outcome

Novel therapeutic insights into the treatment of pericarditis: Targeting the innate immune system

Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Genetic variants in patients with multiple arterial aneurysms